Natural Inhibitors of Mammalian α-Amylases as Promising Drugs for the Treatment of Metabolic Diseases

α-Amylase is a generally acknowledged molecular target of a distinct class of antidiabetic drugs named α-glucosidase inhibitors. This class of medications is scarce and rather underutilized, and treatment with current commercial drugs is accompanied by unpleasant adverse effects. However, mammalian...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalinovskii, Aleksandr P., Sintsova, Oksana V., Gladkikh, Irina N., Leychenko, Elena V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671682/
https://www.ncbi.nlm.nih.gov/pubmed/38003703
http://dx.doi.org/10.3390/ijms242216514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671682/
https://www.ncbi.nlm.nih.gov/pubmed/38003703
http://dx.doi.org/10.3390/ijms242216514

Ejemplares similares